Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group - Revista Brasileira de Ginecologia e Obstetrícia
Penna IAA. Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group. Rev Bras Ginecol Obstet 2005;26(10):218.
Electronic Document Format (ABNT)
Penna, Ivan Andrade de Araujo. Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group. Rev Bras Ginecol Obstet, v. 26, n. 10, p. 218-218, Feb. 2005.
Electronic Document Format (APA)
Penna, I. A. A. (2005). Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group. Rev Bras Ginecol Obstet, 26(10), 218-218.
Electronic Document Format (ISO)
Penna, Ivan Andrade de Araujo. Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group. Rev Bras Ginecol Obstet [online]. 2005, vol. 26, n. 10, [cited 2024-06-30], pp.218-218. Available from: <https://journalrbgo.org/article/use-of-150-mg-day-acarbose-in-obese-patients-with-polycystic-ovary-syndrome-a-double-blind-randomized-study-with-a-placebo-group/>.
✕
Use of 150 mg/day acarbose in obese patients with polycystic ovary syndrome: a double-blind randomized study with a placebo group |
Comments